Stablecoin Development Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $30.9M
- Price
- $1.14
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.79%
- Volume
- 10.5M
About
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Quick stats
Shares outstanding27.1M
Computed float27.1M
Float / shares100.0%
Key info
SectorHealthcare
IndustryMedical - Pharmaceuticals
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001389545
Websitehttps://stabledev.com
AI Summary
AI-generated1/8
minorneutrallegal litigation
SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly Novabay Pharmaceuticals, Inc.) Stockholders
Abbott Cooper PLLC announced an investigation into potential breaches of fiduciary duties by the board of Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.).
The firm is soliciting stockholders who have continuously held shares since prior to August 19, 2025, to contact the firm regarding their legal rights.
This is a contingency-fee solicitation with no cost to stockholders unless a recovery is obtained.